1. Home
  2. PYPD vs HTCR Comparison

PYPD vs HTCR Comparison

Compare PYPD & HTCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PYPD
  • HTCR
  • Stock Information
  • Founded
  • PYPD 2008
  • HTCR 2009
  • Country
  • PYPD Israel
  • HTCR Japan
  • Employees
  • PYPD N/A
  • HTCR N/A
  • Industry
  • PYPD Medical/Dental Instruments
  • HTCR EDP Services
  • Sector
  • PYPD Health Care
  • HTCR Technology
  • Exchange
  • PYPD Nasdaq
  • HTCR Nasdaq
  • Market Cap
  • PYPD 24.2M
  • HTCR 24.4M
  • IPO Year
  • PYPD 2020
  • HTCR 2022
  • Fundamental
  • Price
  • PYPD $3.56
  • HTCR $1.12
  • Analyst Decision
  • PYPD Strong Buy
  • HTCR
  • Analyst Count
  • PYPD 2
  • HTCR 0
  • Target Price
  • PYPD $12.00
  • HTCR N/A
  • AVG Volume (30 Days)
  • PYPD 8.1K
  • HTCR 136.1K
  • Earning Date
  • PYPD 11-13-2024
  • HTCR 11-14-2024
  • Dividend Yield
  • PYPD N/A
  • HTCR 7.08%
  • EPS Growth
  • PYPD N/A
  • HTCR N/A
  • EPS
  • PYPD N/A
  • HTCR N/A
  • Revenue
  • PYPD N/A
  • HTCR $17,129,427.00
  • Revenue This Year
  • PYPD N/A
  • HTCR $57.65
  • Revenue Next Year
  • PYPD N/A
  • HTCR N/A
  • P/E Ratio
  • PYPD N/A
  • HTCR N/A
  • Revenue Growth
  • PYPD N/A
  • HTCR N/A
  • 52 Week Low
  • PYPD $2.95
  • HTCR $0.45
  • 52 Week High
  • PYPD $9.20
  • HTCR $1.55
  • Technical
  • Relative Strength Index (RSI)
  • PYPD 54.93
  • HTCR 53.01
  • Support Level
  • PYPD $3.30
  • HTCR $0.98
  • Resistance Level
  • PYPD $3.59
  • HTCR $1.38
  • Average True Range (ATR)
  • PYPD 0.21
  • HTCR 0.12
  • MACD
  • PYPD 0.02
  • HTCR -0.01
  • Stochastic Oscillator
  • PYPD 68.27
  • HTCR 35.32

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

About HTCR Heartcore Enterprises Inc.

HeartCore Enterprises Inc is a software development company. It provides software through two business units. The first business unit includes a customer experience management business that has been in existence for 12 years. The customer experience management platform includes marketing, sales, service and content management systems, as well as other tools and integrations, that enable companies to attract and engage customers throughout the customer experience. It also provides education, services and support to help customers be successful with the CXM Platform. The second business unit, its DX division, is a digital transformation business that provides customers with robotics process automation, process mining and task mining to accelerate the digital transformation of enterprises.

Share on Social Networks: